Howard W. Robin
President & CEO at Nektar Therapeutics
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Nektar Therapeutics, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Nektar Therapeutics June 5, 202672.6%
-
Nektar Therapeutics June 8, 202397.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Nektar Therapeutics | Open-market sale | −418 | $71.98 | $30,088 |
| Jun 17, 2026 | Nektar Therapeutics | Open-market sale | −5,500 | $60.81 | $334,455 |
| Jun 17, 2026 | Nektar Therapeutics | Open-market sale | −4,500 | $61.65 | $277,425 |
| Jun 16, 2026 | Nektar Therapeutics | Open-market sale | −5,303 | $59.97 | $318,021 |
| Jun 16, 2026 | Nektar Therapeutics | Open-market sale | −4,697 | $60.71 | $285,155 |
| May 19, 2026 | Nektar Therapeutics | Open-market sale | −444 | $65.51 | $29,086 |
| Feb 18, 2026 | Nektar Therapeutics | Open-market sale | −423 | $73.00 | $30,879 |
| Dec 22, 2025 | Nektar Therapeutics | Grant or award | +21,667 | — | — |
| Nov 25, 2025 | Nektar Therapeutics | Open-market sale | −2,207 | $54.28 | $119,796 |
| Nov 21, 2025 | Nektar Therapeutics | Grant or award | +7,110 | — | — |
| Sep 9, 2025 | Nektar Therapeutics | Open-market sale | −2,100 | $45.16 | $94,836 |
| Sep 9, 2025 | Nektar Therapeutics | Open-market sale | −1,200 | $46.41 | $55,692 |
| Sep 9, 2025 | Nektar Therapeutics | Open-market sale | −2,156 | $47.49 | $102,388 |
| Sep 9, 2025 | Nektar Therapeutics | Open-market sale | −1,210 | $48.18 | $58,298 |
| Sep 5, 2025 | Nektar Therapeutics | Open-market sale | −3,304 | $37.87 | $125,122 |
Questions about Howard W. Robin
What boards is Howard W. Robin on?
Howard W. Robin sits on the board of Nektar Therapeutics.
What company is Howard W. Robin the CEO of?
Howard W. Robin is President & CEO of Nektar Therapeutics.
How long has Howard W. Robin served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.